Open AccessBibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics
Author(s) -
Haotian Jiang,
Yuan Li,
Yinghui Liu,
Weiguo Dong
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0086
Subject(s) - medicine , web of science , bibliometrics , n6 methyladenosine , china , cancer , oncology , bioinformatics , library science , meta analysis , gene , geography , biology , genetics , archaeology , computer science , methyltransferase , methylation
Background: N6-methyladenosine (m 6 A) is crucial in cancer and is being intensively studied. Aim: This bibliometric analysis seeks a broad picture of the role of m 6 A in cancer to guide and broaden future research. Methods: Publications were retrieved from Web of Science Core Collection and PubMed from 2000 to 2021, with keywords ‘m 6 A’ and ‘cancer’, and analyzed in biblioshiny and VOSviewer. Results: A total of 1013 documents were included, and China and the USA were the top countries with close collaboration. Mechanisms and predictive biomarkers of m 6 A regulator genes were highlighted. Cross-integration of m 6 A and other research hot spots, including ‘immunotherapy’, ‘hypoxia' and ‘polymorphism’, were frontiers of m 6 A in cancer. Conclusion: This bibliometric study offered an updated perspective on m 6 A in cancer.